Articles with keyword cancer

• Cancer moonshot

  F.V. Moiseenko, V.M. Moiseyenko

  cancer, solid tumors treatment, innovations, perspective research

• CANCER IMMUNOTHERAPY

  N.M. Volkov

  cancer immunotherapy, immune check-point inhibitors, chimeric antigen receptor, clinical trials.

• Immunity and cancer

  Z.G. Kadagidze, A.I. Chertkova

  cancer immunoediting, T-effectors, regulatory T cells, NK cells, NKT cells, macrophages, myeloid-derived suppressor cells

• BIOLOGY OF BREAST CANCER

  E.N. Imyanitov

  pathogenesis of breast cancer, metastasis of breast cancer, breast cancer therapy, hereditary breast cancer.

• Cancer screening and mortality

  A.A. Barchuk, A.M. Belyaev, A.V. Filochkina, A.I. Arseniev, Anssi Auvinen

  cancer screening, mortality, study design, randomized trial, bias, breast cancer, mammography, lung cancer, computed tomography, cervical cancer, cytology, human papillomavirus, prostate cancer, prostate-specific antigen

• Overdiagnosis of thyroid cancer

  D.G. Zaridze, I.S. Stilidi, A.D. Kaprin, D.M. Maksimovich

  thyroid cancer, incidence, mortality, trends, latent cancer, non-invasive follicular neoplasia, ultrasound screening, survival, overdiagnosis

• History of cancer hormonothe

  N.K. Abduloeva, M.V. Scriabin, О.А. Skripko, S.K. Kaitova, R.A. Ryandjina, K.N. Kazakova, V.M. Moiseenko

  breast cancer, epidemiology, risk factors, classification, diagnosis, prognosis, marker, treatment, Lobular carcinoma in situ ((DCIS), time to progression (TTP), complete regression, partial regression, metastatic breast cancer (MBC), median progression-free survival (PFS), overall response, LH-RH agonists and antagonists, receptor estrogen, LH-releasing hormone, Gonadotropin-releasing-hormone-receptor antagonists, overall survival, prostate cancer, Castration-resistant prostate cancer (CRPC), receptor androgens, prostate-specific antigen (PSA)

• YOUNG AGE: CANCER, PREGNANCY, FERTILITY

  A.A. Parokonnaya

  cancer and pregnancy, cancer and reproduction, fertility, oncology, cryopreservation.

• CHEMORADIOTHERAPY OF VIRUS-ASSOCIATED TUMORS (CANCER OF THE HEAD AND NECK, CERVIX CANCER AND ANAL CANCER)

  Yu.N. Vinogradova, V.P. Sokurenko, N.Yu. Neklasova, E.A. Maslyukova, A.I. Chumachenko, A.D. Kuznetsov, N.V. Ilyin

  virus-associated tumors, head and neck cancer, cervical cancer, anal cancer, chemoradiotherapy.

• NEOADJUVANT CHEMOTHERAPY FOR HEREDITARY BREAST CANCER

  E.M. Bit-Sava, V.F. Semiglazov, E.N. Imyanitov, V.M. Moiseyenko

  breast cancer, triple negative breast cancer, hereditary breast cancer

• PREVENTION OF VIRUS-ASSOCIATED CANCERS

  А.A. Barchuk

  prevention, vaccination, virus-associated cancers, antiviral therapy, screening.

• Surgical treatment of hepatocellular cancer

  J. Chinburen, D.T. Arybzhanov

  liver, extended hepatectomy, tumor, liver resection, surgery, hepatocellular cancer.

• A history of cancer immunotherapy

  V.M. Moiseyenko, N.M. Volkov

  anticancer immunity, cancer immunotherapy, history, vaccines, cytokines, adoptive therapy, antibody, immune check-point inhibitor

• Early cancer detection: current status and emerging strategies

  Francisco Gutierrez-Delgado

  early cancer detection, cancer screening, breast cancer, mammography, breast thermography, cancer imaging, cancer biomarkers, lung cancer

• GYNAECOLOGICAL CANCER IN PATIENTS OF REPRODUCTIVE AGE

  S.Ya. Maximov, A.S. Khadzhimba, A.A. Ilin I.V. Sobolev, E.A. Vishinskaya

  ovarian cancer, endometrial cancer, cervical cancer, reproductive age, morbidity, mortality, treatment

• BIOLOGY CHRACTERISTICS IN UROLOGICAL CANCERS DEVELOPEMENT

  P.S. Borisov, R.V. Orlova, E.E. Topuzov

  urothelial carcinoma, muscle invasive bladder cancer (MIBC), non-muscle invasive bladder cancer (NMBC), FGFR3, TP53, oncogene, mutation load, genetic profiling.

• CANCER IN YOUNG AGE: DIGESTIVE TRACT TUMORS

  N.M. Volkov

  digestive tract tumors, young age, hereditary cancer syndromes, incidence, colorectal cancer, gastric cancer.

• CONTEMPORARY ASPECTS OF TREATMENT METASTATIC PROSTATE CANCER

  A.K. Nosov, S.A. Reva, M.V. Berkut

  prostate cancer, cabazitaxel, docetaxel, abiraterone, enzalutamide.

• NEW APPROACHES IN BREAST CANCER SURGERY

  E.M. Bit-Sava, V.V. Egorenkov, A.O. Damenia, O.A. Melnikova, R.M. Akhmedov, M.A. Monogarova, M.G. Anchabandze, V.M. Moiseyenko.

  breast cancer, breast conserving surgery, oncoplastic surgery, reconstructive-plastic surgery, endoscopic mastectomy, biopsy of sentinel lymph nodes.

• EVOLUTION OF SCREENING FOR PROSTATE CANCER

  A.I. Novikov

  prostate cancer, screening, prostate-specific antigen (PSA), prostate health index, multiparameter magnetic-resonance tomography (mpMRI), biomarkers (Select MDX, HOXX6, DLX1), genetic mutations (BRCA1/2, HOXB13).

• MOLECULAR TARGETS IN LUNG CANCER: CURRENT STATUS

  E.N. Imyanitov

  lung cancer, mutation, smoking, tumor, inhibitor

• EVOLUTION OF TREATMENT OF PANCREATIC HEAD CANCER

  M.V. Zemko, R.I. Rasulov, K.G. Zubrinsky, G.I. Songolov

  pancreas cancer, adjuvant treatment, neoadjuvant treatment, radical operation, pancreatoduodenal resection

• RECONSTRUCTIVE AND PLASTIC SURGERY FOR BREAST CANCER

  V.A. Sobolevsky, V.Ju. Ivashkov, N.I.G. Mehtiyeva

  breast reconstruction, breast cancer, skin-fat flap, DIEP.

• Clinical management of peritoneal metastases from colorectal cancer

  D. Baratti, Sh. Kusamura, M. Guaglio, M. Deraco

  colorectal cancer, peritoneal metastasis, cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, HIPEC, liver metastasis

• Prevention – the most effective method of cancer control

  D.G. Zaridze

  cancer prevention, epidemiology, risk factors, etiology, incidence, mortality

• Role of cytoreductive surgery for metastatic gastrointestinal cancer – views of medical oncologist

  M.Ju. Fedyanin

  esophageal cancer, gastric cancer, colorectal cancer, cytoreductive surgery, metastatic tumor, metastasectomy

• The role of androgen receptor in breast cancer. Reviewwork

  Y.I. Kochetkova, M.A. Frolova, M.B. Stenina

  breast cancer, androgen receptors, endocrine therapy.

• Features of the clinical course of hiv-associated cervical cancer

  M.P. Smirnova, A.S. Khadgimba, S.Y. Maksimov, G.S. Samedzade

  HIV-infection, cervical cancer, immunosuppression.

• RADIOSURGICAL TREATMENT OF BRAIN METASTASES FROM GASTROINTESTINAL CANCER

  P.I. Ivanov, .S. Zubatkina, V.V. Krasnyuk, А.V. Kuzmin, N.А. Vorobyov

  brain metastases, gastrointestinal cancer, Gamma-Knife, prognostic factors, RPA classes.

• ARE WE ALWAYS USING CORRECT APPROACHES IN CANCER TREATMENT?

  F.V. Moiseenko, V.M. Moiseyenko

  cancer, treatment, tumor kinetics, modeling, adaptive regimens.

• Breast and prostate cancer oligometastases: the feasibility of surgery treatment

  M.P. Nikulin

  breast cancer, prostate cancer, surgery, oligometastasis, oligometastases, oligometastatic, metastasectomy, solitary metastases

• Neoadjuvant endocrine therapy for breast cancer: state of the art

  А.А. Zavialov, A.I. Tyryshkin, S.E. Varlamova.

  breast cancer, neoadjuvant treatment, hormone therapy.

• SURGICAL FEATURES IN BREAST CANCER (BC) PATIENTS OF YOUNG AGE

  A.V. Petrovskyi, V.A. Amosova

  breast cancer, young age, surgical treatment.

• Surgical treatment of locally advanced and metastatic kidney cancer

  A.I. Novikov, R.V. Leonenkov, L.M. Rodygin

  kidney cancer, renal cell carcinoma, cytoreductive surgery, lymphadenectomy, metastasectomy, thrombectomy.

• PROMISING METHODS FOR THE TREATMENT OF METASTATIC BREAST CANCER

  A.S. Zhabina

  metastatic breast cancer, high-dose chemotherapy, metronome therapy, vaccine therapy, adoptive therapy.

• Multimodal prehabilitation in patients with colorectal cancer: a systematic review

  R.A. Nurmukhametov, T.S. Dikova, V.К. Lyadov, К.А. Kulbasova, V.N. Galkin

  systematic review, prehabilitation, multimodal, colorectal cancer, colorectal surgery, outcomes.

• Value of adjuvant chemotherapy for colon and rectal cancer from a surgeon’s point of view

  M. Kornmann, S. Paschke

  adjuvant treatment, chemosensitivity, colon cancer, rectal cancer, 5-fluorouracil, oxaliplatin

• Transanal surgery in LST and early forms of rectum cancer

  I.A. Nechai, E.P. Afanasyieva, N.P. Maltsev

  villous laterally spreading tumor, rectal cancer, transanal excision, transanal endoscopic microsurgery

• Immune checkpoint inhibitors in the treatment of cervical cancer: literature review

  O.A. Pardabekova

  cervical cancer, immunotherapy, immune checkpoint inhibitors, pd-1,

• XXI CENTURY DIAGNOSTIC ALGORITHMS. ARTIFITIAL INTELLIGANCE IN LUNG CANCER DETECTION

  A.A. Meldo, L.V. Utkin, V.M. Moiseyenko

  artifitial intelligence, mashine learning, lung cancer, diagnostic, computed tomography, neural network.

• Prevention of smoking-associated forms of cancer: harm reduction concept

  D.G. Zaridze, A.F. Mukeria

  trends, smoking prevalence, mortality, lung cancer, nicotine replacement therapy, electronic nicotine delivery systems, harm reduction.

• Hormone replacement therapy in patients with a history of cancer

  N.E. Levchenko, E.A. Efremov, E.V. Kasatonova, Yu.S. Sidorenko, Y.I. Melnik, A.V. Koryakin

  cancer survivor, estrogen replacement, testosterone replacement, HRT, hormone replacement therapy, MHT, menopausal hormone therapy, recurrence risk.

• Possibilities of intraoperative radiation therapy in the treatment of breast cancer patients

  Е.М. Bit-Sava, L.A. Gor, S.B. Bakhovadinova, М.А. Monogarova, М.G. Kurbanova, А.О. Damenia, А.М. Khabicheva, Т.S. Dzhukaeva, К.В. Mikhail, А.S. Zhurov, V.M. Moiseenko

  breast cancer, intraoperative radiotherapy, multimodal treatment, organ-preserving surgery.

• DUCTAL CANCER OF PANCREATIC HEAD NEOADJUVANT TREATMENT: CLOSE AND END RESULTS

  R.I. Rasulov, M.V. Zemko, I.V. Ushakova, G.I. Songolov

  pancreatic head cancer, neoadjuvant treatment, gastroduodenal artery chemoembolization, radiation therapy.

• Direct photogeneration of singlet oxygen in biological medium for cancer therapy

  A.A. Bogdanov, V.V. Klimenko, An.A. Bogdanov, N.A. Verlov, V.M. Moiseyenko

  single oxygen, direct photogeneration, reactive oxygen species, cancer therapy, photobiomodulation.

• Palliative resections in metastatic colorectal cancer: to whom and when? literature review

  I.I. Aliev, D.A. Ivlev, A.Y. Berdinskikh, E.Y. Klimov.

  colorectal cancer, hepatic metastases, palliative surgery, overall survival.

• Results of transanal mesorectal excision for rectal cancer – single center experience

  A.O. Rasulov, Z.Z. Mamedli, H.E. Jumabaev, V.M. Kulushev, N.A. Kozlov

  trans-anal TME, laparoscopic TME, rectal cancer, minimal invasive surgery, neoadjuvant chemoradiation

• Local treatment options for colorectal cancer patients with lung metastases: a literature review

  T.S. Boldyreva, М.Е. Ivannikov, Y.S. Yesakov, V.K. Lyadov

  colorectal cancer, prognostic factors, lung metastases, oligometastases, surgical treatment for lung metastases, radiofrequency ablation, stereotactic radiotherapy

• Choosing the stage of treatment in patients with advanced forms of ovarian cancer

  V.V. Saevets, E.A. Ulrich, D.M. Rostovcev, A.Yu. Shamanova, А.A. Mukhin, S.I. Samodurov, А.V. Taratonov, Е.S. Glazyrina

  ovarian cancer, surgical treatment, interval cytoreduction, primary cytoreduction

• MOLECULAR-ORIENTED AND PRECISION CANCER THERAPY – THE PRESENT AND FUTURE ASPECTS

  D.B. Korman

  cancer, molecular-oriented drugs, precision therapy, sequencing DNA, tumor-associated mutations, tumor-type agnostic therapy.

• Stereotactic radiotherapy vs. surgery in the treatment of colorectal cancer liver oligometastases

  A.N. Moskalenko, V.K. Lyadov, M.V. Chernykh, I.V. Sagaydak, D.G. Ichshanov, M.R. Garipov, V.N. Galkin.

  Stereotactic radiation therapy, colorectal cancer, oligometastatic liver disease, hepatic resection.

• Comparison of laparoscopic and traditional multivisceral resections in locally advanced colorectal cancer

  I.L. Chernikovskiy, I.I. Aliev, N.V. Savanovich, A.V. Gavriliukov

  locally-advanced colorectal cancer, multivisceral resections, laparoscopic colorectal surgery, T4 cancer of colon and rectum, laparoscopic resections of colon and rectum

• Intraperitoneal chemotherapy in patients with advanced ovarian cancer: phase 2 institutional study

  A.S. Tyulyandina, V.М. Nechushkina, L.V. Cherkes, K.Y. Morkhov, A.A. Rumyantsev, I.A. Pokataev, E.V. Glazkova, E.R. Virshke, D.Y. Frantsev, K.I. Zhordania, Y.V. Bujdenok, R.K. Valiev, A.V. Petrovsky, Y.S. Sergeev, I.V. Panichenko, A.A. Bulanov, M.B. Stenina, S.A. Tyulyandin

  ovarian cancer, intraperitoneal chemotherapy, intravenous chemotherapy, optimal cytoreduction, cisplatin, paclitaxel.

• The most important results of clinical trials for breast cancer systemic therapy in 2021

  S.A. Tjulandin, М.В. Stenina, М.А. Frolova

  breast cancer, immunotherapy, endocrine therapy, chemotherapy, gene expression assay, BRCA1/2-associated breast cancer.

• About features of quality examination of medical care to patient metastatic kidney cancer

  K.N. Movchan, K.E. Chernov, V.V. Tatarkin, B.S. Artyushin, A.V. Zharkov, A.Y. Chernova, E.V. Zhelezny

  malignant neoplasms, kidney tumors, metastatic kidney cancer, quality of care.

• EVOLUTION OF DRUG THERAPY FOR LUNG CANCER WITH EGFR INHIBITORS: NEW ASPECTS

  M.L. Stepanova, L.V. Khalicova, A.S. Zhabina, F.V. Moiseenko

  non-small cell lung cancer, epidermal growth factor receptor, targeted therapy, osimertinib.

• Surgical results of lung cancer treatment it patients with concomitant coronary artery disease

  S.S. Gerasimov, M.V. Serebryanskaya, M.I. Davydov, R.S. Akchurin, Y.I. Buziashvili, E.P. Golubev, E.R. Charchyan, D.V. Puzenko, P.V. Kononets

  lung cancer, coronary artery disease, lobectomy, bilobectomy, pneumonectomy, coronary artery bypass surgery, coronary angioplasty.

• EVOLUTION OF TYROSINE KINASE RESISTANCE IN EGFR MUTATED NON-SMALL CELL LUNG CANCER

  F.V. Moiseenko

  non-small cell lung cancer, epidermal growth factor receptor, targeted therapy, resistance.

• Carcinogenesis associated with tobacco smoke and prospects for using alternative nicotine delivery systems in cancer prevention

  N.G. Berdnikova, A.V. Zagurskaya, V.A. Menshov, A.V. Trofimov, O.I. Yablonskaya, V.D. Kancheva, R.M. Balansky

  alternative nicotine delivery systems, smoking, cancer prevention.

• CHANGES IN NEO- AND ADJUVANT TREATMENT OF BREAST CANCER IN THE LAST 5 YEARS

  M.B. Stenina, M.A. Frolova, D.Z. Kupchan, S.A. Tjulandin

  early breast cancer, neo-adjuvant therapy, adjuvant therapy, radiotherapy, chemotherapy, hormonotherapy, anti-HER2 therapy, ovarian suppression.

• INDICATIONS FOR LYMPH NODE DISSECTION IN PATIENTS WITH VULVAR CANCER. LITERATURE REVIEW AND OWN CLINICAL OBSERVATIONS

  А.А. Ilin, S.Y. Maximov, А.S. Khadgimba, I.V. Sobolev, S.H. Kaitova

  vulvar cancer, metastasis, lymph node dissection, risk factors, vulvectomy.

• Clinical experience of afatinib application In non-cell lung cancer of lung. Ii line of therapy

  L.M. Kogoniya, E.V. Markarova, G.A. Stashuk, V.E. Shikina

  lung cancer, adenocarcinoma, non-small cell lung cancer, EGFR mutation, chemotherapy, targeted therapy, efficacy, elderly, side effects

• Effect of surgical risk factors on the short-term outcomes for rectal cancer surgery. Laparoscopic or robotic approach?

  M.E. Moiseev, D.V. Gladyshev, V.A. Vetoshkin, S.A. Kovalenko, R.A. Murashko, S.Z. Hondziya, V.Yu. Svitich, S.S. Gnedash

  robotic surgery, rectal cancer, oncology, risk factors.

• Assessment of the quality of life of breast cancer patients after various types of surgical interventions

  М.А. Monogarova, Е.М. Bit-Sava, М.G. Kurbanova, А.О. Damenia, V.M. Moiseenko

  breast cancer, surgical treatment, radical resection, autologous tissues, endoprosthesis, immediate reconstructive plastic surgery, quality of life.

• THE METHYLATION STATUS ROLE OF FIVE 3p21.31 REGION GENES IN THE MOLECULAR SUBTIPS OF BREAST CANCER PATHOGENESIS

  D.A. Ryabchikov, E.A. Filippova, I.V. Pronina, A.M. Burdenny, S.C. Lukina, T.P. Kazubskaya, I.K. Vorotnikov, I.A. Dudina, A.M. Kazakov, O.A. Talipov, V.I. Loginov, E.A. Braga, K.S. Titov

  luminal and non-luminal breast cancer, gene methylation, promoter region, CpG-island.

• Concept of 3D lymph node dissection and complete mesocolic excision in surgical treatment of colon cancer

  A.M. Karachun, D.V. Samsonov, A.S. Petrov, S.M. Pazhitnov, L.L. Panayotti

  colorectal cancer, surgical treatment, extended lymph node dissection, D3 lymph node dissection, complete mesocolic excision, central ligation of vessels

• Relationship between molecular genetic and clinical and morphological parameters in patients with stage i–iiia non-small cell lung cancer

  А.М. Kazakov, К.К. Laktionov, К.А. Sarantseva, М.G. Gordiev

  targeted sequencing, somatic mutations, non-small cell lung cancer

• Relevance and justification of sublobar resection in early peripheral non-small cell lung cancer in the era of dominance of lobectomy

  G.A. Baksiyan, A.A. Zavialov .

  Sublobar resections, wedge lung resection, anatomical lung resection, early peripheral non-small cell lung cancer.

• The role of liquid biopsy in the choice of tactics For the treatment of non-small cell lung cancer

  K.K. Laktionov, A.M. Kazakov, K.A. Sarantseva, E.V. Reutova, A.L. Arzumanyan, N.M. Moskalyuk

  non-small cell lung cancer, fluid biopsy, mutation profile, minimal residual disease

• The role of using circulating tumor dna in the treatment of disseminated patients with non-small cell lung cancer

  К.К. Laktionov, А.М. Kazakov, М.G. Gordiev

  circulating tumor DNA, tumor mutation burden, non-small cell lung cancer, immunotherapy.

• First line dosointensive chemotherapy for Disseminated ovarian cancer after non optimal Cyted reduction: Results of the phase ii study

  A.A. Rumyantsev, A.S. Tyulyandina, I.A. Pokataev, K.Yu. Morkhov, V.M. Nechushkina, V.E. Nikulin, S.O. Nikogosyan, K.I. Zhordania, S.A. Tyulyandin

  ovarian cancer, dose-dense chemotherapy, dose-intensive chemotherapy, suboptimal debulking, non-optimal debulking.

• Neoadjuvant anti PD-1 / PD-L1 immune checkpoint inhibitors in locall y advanced gastric cancer with microsatellite insta bility

  A.Y. Navmatulya, V.A. Chubenko, S.A. Savchuk, F.R. Almukhametova, P.Y. Tsuprun, A.I. Kuznetsov, G.S. Inusilaev, V.A. Heinstein, K.V. Shelekhova, Е.М. Zykov, B.I. Miroshnikov, V.M. Moiseenko

  Gastric cancer, immune checkpoint inhibitors, MSI, microsatellite instability, PD-1, PD-L1, objective response, pathologic response.

• FIFTEEN COURSES OF SELECTIVE INTRA-ARTERIAL CHEMOTHERAPY FOR RELAPSE OF CANCER OF THE ORAL MUCOSA IN ONE PATIENT

  M.S. Olshansky, A.Yu. Shklyarov, Yu.S. Konstantinova, E.N. Suhochev, S.A. Stikina, A.N. Redkin

  squamous cell carcinoma of the head and neck, relapse of oral cavity cancer, chemoradiation treatment, intraarterial chemotherapy.

• THE HISTORY OF SENTINEL NODE BIOPSY IN HEAD AND NECK CANCER: FROM VISUALIZATION OF LYMPHATIC VESSELS TO SENTINEL NODES (REVIEW)

  M.A. Kotov, Z.A.-G. Radzhabova, S.S. Artemiev, E.O. Stepanova, M.A. Radzhabova

  head and neck tumors, oral cavity cancer, biopsy of the signaling lymph nodes.

• Dynamics of pathological factors after «test» course of preoperative endocrine therapy in menopausal patients with earlyer positive breast cancer and its effect on survival

  M.A. Frolova, M.B.Stenina, Y.I. Kochetkova, A.V. Petrovsky, O.V. Krohina, Y.V. Vishnevskaya, S.A. Tyulyandin

  ER positive breast cancer, preoperative endocrine therapy, Ki67.

• IMPLEMENTATION OF AN INNOVATIVE APPROACH IN MEDICINE ON THE EXAMPLE OF THE INTELLECTUAL SYSTEM OF LUNG CANCER DIAGNOSIS «DOCTOR AIZIMOV»

  A.A. Meldo, L.V. Utkin, V.M. Moiseyenko, T.N. Trofimova, A.A. Lukashin, M.A. Ryabinin

  diagnostic system, lung cancer, Doctor AIzimov, quality of medical care, patient, radiation diagnosis.

• MOLECULAR BIOLOGICAL ASPECTS IN PREDICTING THE LONG-TERM RESULTS OF SURGICAL TREATMENT FOR LOCALLY ADVANCED COLORECTAL CANCER IN PATIENTS OF OLDER AGE GROUPS

  G.M. Manikhas, N.A. Maistrenko, A.A. Sazonov

  locally advanced colorectal cancer, immunohistochemical diagnosis, molecular profile of the tumor, geriatric patients.

• Debulking surgery in oncogynecology

  S.Ya. Maximov, I.V. Sobolev, A.S. Hadjimba, A.A. Ilin, E.D. Gershfeld, D.-K. Reyes Santiago

  cytoreductive, debulking surgery, ovarian cancer, cervical cancer, endometrial cancer, chemotherapy, radiotherapy

• NEW APPROACHES TO ADJUVANT THERAPY OF MALIGNANT TUMORS

  K.S. Titov, A.V. Krasnorutsky, A.M. Kazakov, D.A. Ryabchikov

  adjuvant chemotherapy, breast cancer, colorectal cancer, melanoma, sarcoma.

• What has changed in clinical oncology practice In 2019?

  M.Y. Fedyanin

  cancer, chemotherapy, immunotherapy, targeted therapy.

• Vaccination against hpv is the most effective of the known methods of primary prevention of malignant tumors

  D.G. Zaridze, A.F. Mukeria, I.S. Stilidi

  vaccination, human papilloma viruses, cervical cancer, anogenital tumors, oropharyngial cancer.

• Immunotherapy Resistance – Finding Solutions

  M.Yu. Fedyanin

  cancer, chemotherapy, immunotherapy, resistance.

• THE SUCCESSFUL APPLICATION OF A DOCETAXEL AND MITOTANE THERAPEUTIC COMBINATION IN THE FOURTH LINE TREATMENT OF ADVANCED ADRENOCORTICAL CARCINOMA: A CASE REPORT

  A.A. Kolomeytseva, G.S. Emelianova, A.A. Fedenko

  adrenocortical cancer, docetaxel, mitotane

• Assessment of the frequency of BRCA1/2 muta ions detection by means of PCR in State Budgetary Healthcare Institution «Saint-Petersburg clinical scientific and practical center for specialised types of medical care (oncological) named after N.P. Napalkov»

  N.K. Abduloeva, O.A. Skripko, M.V. Scriabin, F.V. Moiseenko, A.S. Zhabina, V.V. Yegorenkov, N.G. Nikulushkin, N.M. Volkov, K.N. Kazakova, S.K. Kaitova, K.V. Shelekhova, V.M. Moiseenko

  1/2 germinal mutation, polymerase chain reaction, breast cancer, ovarian cancer, Russian Federation, metastatic prostate cancer (MRC), pancreatic cancer (RPlC).

• FUTURE OF SYSTEMIC THERAPY IN ONCOUROLOGY: TARGETED AND IMMUNOTHERAPY

  F.V. Moiseenko

  immunotherapy, targeted therapy, checkpoint inhibitors, urothelial cancer, renal cell cancer.

• 2018 NOBEL PRIZE IN PHYSIOLOGY OR MEDICINE

  F.V. Moiseenko, V.M. Moiseyenko

  cancer, treatment, immunotherapy, checkpoint inhibitors.

• USE OF NON-RADICAL CYTOREDUCTIVE SURGERY IN ONCOUROLOGICAL TUMORS

  R.V. Leonenkov, P.S. Borisov, A.I. Novikov

  cytoreductive operation, metastasectomy, renal cell carcinoma, urothelial cancer, prostate cancer.

• Microbiome as a therapeutic target

  F.V. Moiseenko

  drug therapy, cancer, microbiome, immunotherapy.

• Microbiome and its role in oncology

  F.V. Moiseenko, S.V. Ugai, N.M. Volkov

  drug therapy, cancer, microbiome, immunotherapy.

• Possibilities of cytostatics, hormonal and targeted therapy for operable tumors

  N.V. Levchenko

  adjuvant therapy, targeted therapy, combination hormonal therapy, breast cancer, lung cancer

• SURGICAL METHODS OF TREATMENT IN ONCOLOGY: FROM EXPANDED TO minimally invasive OPERATIONS

  Sh.Kh. Gantsev, Sh.R. Kzyrgalin, K.Sh. Gantsev

  cancer, surgical operations, lymph node, metastasis

• IMMUNOTHERAPY

  N.M. Volkov

  cancer immunotherapy, effectiveness, toxicity, hyperprogression, predictive biomarkers.

• Immunotherapy: Neoadjuvant and/or adjuvant? Literature review

  N.A. Falaleeva, E.A. Bykova, L.Yu. Grivtsova, A.S. Belokhvostova, A.А. Danilenko, I.S. Pimonova, P.V. Shegai, S.A. Ivanov, A.D. Kaprin

  Neoadjuvant immunotherapy, immune checkpoint inhibitors, breast cancer, colorectal cancer, non-small cell lung cancer, nonspecific immunotropic therapy.

• 2016: new directions in radiation therapy

  N.V. Dengina, T.V. Mitin, A.O. Likhacheva

  radiotherapy, breast cancer, prostate cancer, targeted therapy, abscopal effect, hepatocellular carcinoma, intrahepatic cholangiocarcinoma

• LAPAROSCOPIC COLORECTAL SURGERY WITH NATURAL ORIFICE SPECIMEN EXTRACTION (NOSE): SINGLE CENTRE EXPERIENCE

  I.L. Chernikovskiy, A.A. Smirnov, N.V. Savanovich, A.V. Gavriliukov, V.M. Moiseyenko

  laparoscopy, colorectal cancer, transluminal surgery, NOTES.

• Role of supportive care as an element of antitumor treatment

  М.М. Kramchaninov

  cancer, solid tumors, antitumor drugs, supportive therapy

• NEW IN DRUG TREATMENT OF SOLID TUMORS

  V.V. Petkau, I.S. Bulavina

  non-small cell lung cancer, breast cancer, Osimertinib, Alectinib, Ribociclib, Abemaciclib, Neratinib, Olaparib.

• Modern strategies of staging and treatment of hepatocellular carcinoma in cirrhosis

  V.Y. Kosyrev

  hepatocellular cancer; staging systems TNM, BCLC, HKLC.

• What should we consider besides immune checkpoint drugs on the way to improvement of the efficacy?

  F.V. Moiseenko

  cancer, malignant tumors, immunotherapy, metabolism, microbiom.

• SPECIFIC DEMOGRAPHIC DETERMINANTS, THREATS, AND MODERN TRENDS IN MALIGNANT NEOPLASM SCREENING (REVIEW)

  A.N. Zhigulev, V.Yu. Mishlanov, O.A. Orlov, A.V. Katkova

  malignant neoplasms, cancer, demography, threats, screening.

• Prevention and early detection of hereditary tumors

  E.N. Imyanitov

  hereditary cancers, hereditary cancer genes, BRCA1, BRCA2, CHEK2, PALB2, NBS1, BLM, preventive surgery in oncology

• Colorect al molecular subtypes – progress or deadlock ?

  M.Yu. Fedyanin, E.O. Ignatova, А.А. Tryakin

  colorectal cancer, molecular subtypes, immunotherapy, targeted therapy.

• Targeted therapy: twenty years of success and failures

  S.A. Tyulyandin

  targeted therapy, oncology, cancer, melanoma, tumor evolution.

• Possibilities of intraluminal photodynamic therapy in oncology (review)

  A.E. Akkalaeva, V.V. Klimenko, A.A. Avanesyan, V.V. Egorenkov, A.A. Bogdanov, V.M. Moiseyenko

  tumor stenosis, photodynamic therapy, endoscopy, early cancer, photosensitizers.

• Fundamental oncology in 2015: a review of the most interesting discoveries

  E.N. Imyanitov

  сancer immunotherapy, fundamental oncology, microsatellite instability, acquired cancer resistance, circulating tumor DNA, cancer hormonotherapy, KRAS mutation

• Pancreatic tumors: diagnostics and treatment (literature review)

  I.I. Aliev, D.A. Ivlev, A.Y. Berdinskikh

  pancreas, cancer, resectability criteria, neuroendocrine tumors, oncological outcomes.

• The use of brigatinib in the treatment of ALK-positive NSCLC in the progression of crizotinib

  S.Y. Kruteleva, К.К. Laktionov

  non-small cell lung cancer, ALK translocation, brigatinib, resistance.

• BASIC SCIENCE IN ONCOLOGY: YEAR 2017 OVERVIEW

  E.N. Imyanitov

  oncology, microbiome, tumor, cancer treatment methods, medical and biological technologies.

• Comparative evaluation of robot-assisted, laparoscopic and open surgical interventions in the combined treatment of stomach cance

  S.A. Kovalenko., I.I. Dzidzava, D.V. Gladyshev, V.Yu. Svitich, M.E. Moiseev, V.A. Vetoshkin, S.S. Gnedash, G.B. Pavlinov, A.S. Skobaro

  robot-assisted surgery, gastric cancer, oncology, gastric resection, gastrectomy.

• Resistance to targeted therapy

  F.V. Moiseenko, V.M. Moiseyenko

  malignant tumors, lung cancer, molecular markers, targeted therapy, resistance.

• Nutritional support for patients with malignant tumors

  M.Yu. Kukosh, M.D. Ter-Ovanesov, O.A. Gladkov, A.S. Gaboyan, I.M. Borovkov

  palliative care, end-of-life care, cachexia, cancer, nutrition

• Antibody-drug conjugates

  E.O. Stepanova, F.V. Moiseenko, V.M. Moiseyenko

  cancer, solid tumors, antitumor drugs, antibody-drug conjugates, ADC.

• Tumor-agnostic biomarkers

  F.V. Moiseenko

  malignant tumours, cancer, molecular markers, MSI, TMB, BRAF, NTRK.

• New and promising immune oncology drugs combinations

  N.М. Volkov

  malignant tumors, cancer immunotherapy, immune check-point inhibitors, combinations.

• MATHEMATICAL MODELING AND OPTIMIZATION OF TARGETED TUMOR THERAPY

  A.A. Bogdanov

  cancer, targeted therapy, mathematical modeling, forecasting, new regimens of therapy.

• 2015 main events in drug therapy

  F.V. Moiseenko

  immunotherapy, program cell death protein inhibitors, targeted therapy, cancer drug therapy

• Cell-based anticancer immunotherapy methods

  N.M. Volkov

  сell-based immunotherapy, adoptive therapy, dendritic cell, vaccine, T-lymphocyte, natural killer, cancer

• Basic science in oncology: year 2016 overview

  E.N. Imyanitov

  oncology, mechanisms of metastatic spread, interesting findings for basic science in oncology, BRCA1/2-related cancers

• History of immunotherapy of malignant tumors

  M.M. Kramchaninov, V.M. Moiseenko

  cancer, solid tumors, antitumour drugs, immunotherapy, monoclonal antibodies, checkpoint inhibitors

• ARTIFICIAL INTELLIGENCE IN ONCOLOGY: A LOOK INTO THE FUTURE

  Sh.Kh. Gantsev, M.V. Frants.

  artificial intelligence, machine learning, neural networks, automatic recognition, medical imaging, cancer.

• Application of biomedical cell products based on natural killer cells and cytokine-induced killer cells for the treatment of oncological diseases

  A.O. Malasheuskaya, N.G. Antonevich, A.Y. Hancharou

  natural killer cells, cytokine-induced killer cells, biomedical cell product, cancer, immunotherapy.

• GASTRIC ADENOCARCINOMA: A DIVERSITY OF GENETIC DISORDERS N TUMOR CELLS AS A THEORETICAL BASIS FOR THE TARGETED DRUGS DEVELOPMENT

  N.V. Danilova, I.A. Mikhailov, N.A. Oleynikova, P.G. Malkov

  gastric adenocarcinoma, gastric cancer, carcinogenesis, genetic disorders, signaling cascades, oncogenes, tumor growth suppressor genes.

• THE ROLE OF SURGICAL TECHNOLOGIES IN THE TREATMENT OF VIRUS-ASSOCIATED TUMORS ON THE EXAMPLE OF HEPATOCELLULAR CARCINOMA

  P.V. Balakhnin, A.S. Shmelev, E.G. Shachinov

  hepatocellular carcinoma, liver cancer, viral hepatitis, liver cirrhosis, virus-associated tumors, HBV, HCV, chemoembolization, ablation.

• Percutaneous energy-based tumor ablation: principles, technologies, results

  P.V. Balakhnin, A.S. Shmelev, E.G. Shachinov

  radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation, laser ablation, ultrasound ablation, cancer immunotherapy, interventional radiology

• Multifactorial analysis of the dependence of prescribed diagnostic test systems and purchased targeted drugs on the example of lung adenocarcinoma in St.P.

  D.D. Zelikova, D.S. Yurochkin, S.E. Erdni-Garyaev, A.A. Leshkevich, Z.M. Golant, D.A. Chagin, N.M. Volkov, F.V. Moiseenko, V.M. Moiseenko

  Non-small cell lung cancer, EGFR mutation, drug provision, targeted therapy, molecular genetic test systems.

• Surgical decision making in treating patients with metastatic tumors. focus on surgical treatment of peritoneal carcinomatosis

  O.E. Kalinin, V.V. Gushchin

  peritoneal carcinomatosis, cytoreductive surgery, curative surgery, palliative surgery, hyperthermic intraperitoneal chemotherapy, HIPEC, stage IV cancer, metastatic disease

• Modern approa hes to the treatment of primary multiple unilateral synchronous lung tumors (literature review)

  I.V. Mosin, S.M. Nuraliev, A.G. Pavlov, V.M. Moiseenko

  Lung cancer, primary multiple synchronous and metachronous lung tumors, classification, diagnosis, staging, stereotactic radiation therapy, targeted therapy, immunotherapy, anatomical segmentectomy, lobectomy, bronchoplastic surgery.

• DIAGNOSTIC IMAGES AND METHODS OF TUMOR PREVA LENCE DETECTION

  A.A. Meldo, T.V. Kobtsova, L.V. Bashkirov, Yu.N. Logovoi

  radiology, computed tomography, magnetic resonance imaging, diagnostic algorithm, ultrasound diagnostic, hepatic tumors, lung cancer, oncological patient.

• Urgent issues of drug therapy and possible solutions

  E.V. Karabina

  precision oncology, effectiveness of immunotherapy of malignant tumors, effectiveness of chemotherapy of malignant tumors, recovery of patients with advanced cancer.

• Long-lasting full remission after selective intra-arterial chemotherapy for recurrence of locally advanced oral mucosa carcinoma

  I.P. Moshurov, A.N. Redkin, N.A. Znatkova, M.S. Olshansky, A.Yu. Shklyarov, A.V. Tsurikova, S.A. Stikina

  squamous cell carcinoma of the head and neck, relapse of oral cavity cancer, chemoradiation, intra-arterial chemotherapy, chemoembolization.

• POSSIBILITIES AND PROBLEMS OF CLINICAL EMBRYOLOGY IN IVF‑PATIENTS WITH ONCOLOGICAL DISEASES

  N.P. Makarova, A.Yu. Romanov, T.A. Dus, E.A. Kalinina

  oncofertility, assisted reproductive technologies, fertility, IVF, ICSI, cancer patients, cryopreservation, vitrification, in vitro oocyte maturation, IVM, ovarian transplantation, embryology.

• Advanced minimally invasive (traditional, laparoscopic and robot-assisted) methods of surgical treatment of diseases of the right colon. А review of the literature

  D.V. Gladyshev, D.S. Shelegetov, M.E. Moiseev, I.I. Dzidzava, S.A. Kovalenko, S.S. Gnedash

  robot-assisted colectomy, colon cancer, surgical complex «Da Vinci», robot-assisted right hemicolectomy, laparoscopic-assisted right hemicolectomy, a review of the literature

• Assessment of the reliability of the criteria for the consistency of radioiodablation

  V.A. Solodkiy, D.K. Fomin, O.A. Borisova, Y.A. Blanter

  differentiated thyroid cancer, thyroid carcinoma, thyroid remnant, radioiodine ablation, 99mTc-pertechnetate scintigraphy, post therapeutic scintigraphy whole body with 131I, thyroglobulin, TSH, thyroid-stimulating hormone, sodium iodine symporter, radioiodine therapy, thyrotropin alpha, dosimetry